Cardiovascular disease in women: Gender-specific aspects of hypertension and the consequences of treatment

Journal of Women's Health

Volumn 7, Issue 2, 1998, Pages 199-209

  Legato, Marianne J ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b Department of Orthopaedic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTROGEN; LABETALOL; METHYLDOPA; ORAL CONTRACEPTIVE AGENT;

ADRENERGIC SYSTEM; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIET; ESSENTIAL HYPERTENSION; ESTROGEN THERAPY; EXERCISE; FEMALE; GENDER; HEMODYNAMICS; HUMAN; HYPERINSULINEMIA; MORTALITY; POSTMENOPAUSE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; REVIEW; SODIUM RESTRICTION; STROKE; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 0031966725     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1998.7.199     Document Type: Review

References (63)

1. Hunink MG, Goldman L, Tosteson AN, et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA 1997;227:535.
2. Fiebach NH, Hebert PR, Stampfer MJ, et al. A prospective study of high blood pressure and cardiovascular disease in women. Am J Epidemiol 1989;130: 646.
3. American Heart Association. Silent epidemic: The truth about women and heart disease. Dallas, TX: American Heart Association, 1995:9.
4. National High Blood Pressure Education Program. Working Group Report on Primary Prevention of Hypertension. Bethesda, MD: National Heart, Lung and Blood Institute, National Institutes of Health, 1993, National Institutes of Health Publication 93-2669.
5. de Simone G, Devereux RB, Roman MJ, et al. Gender differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in normal adults. Am J Cardiol 1991;68:1704.
6. Anastos K, Charney P, Charon RA, et al. Hypertension in women: What is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine. Ann Intern Med 1991;115:287.
7. Messerli FH, Garavaglia GE, Schmieder RE, Sundgaard-Riise K, Nunez BD, Amodeo C. Disparate cardiovascular findings in men and women with essential hypertension. Ann Intern Med 1987;107:158.
8. Krumholz HM, Larson M, Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol 1993;72:310.
9. Carroll JD, Carroll EP, Feldman T, et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 1992;86:1099.
10. Scheuer J, Malhotra A, Schaible TF, Capasso J. Effects of gonadectomy and hormonal replacement on rat hearts. Circ Res 1987;61:12.
11. Cabrai AM, Vasquez EC, Moyses MR, Antonio A. Sex hormone modulation of ventricular hypertrophy in sinoaortic denervated rats. Hypertension 11(2 Pt2):I93.
12. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345.
13. Devereux RB. Left ventricular mass and stroke. What is the connection? JAMA 1994;272:71.
14. Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study. JAMA 1994;272:33.
15. Schunkert H, Hense HW, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634.
16. Drayer JI, Weber MA, DeYoung JL. BP as a determinant of cardiac left ventricular muscle mass. Arch Intern Med 1983;143:90.
17. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303.
18. Kannel WB. Blood pressure as a cardiovascular risk factor. JAMA 1996;275:1571.
19. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994;90:1786.
20. Gifford RW Jr. What's new in the treatment of hypertension [Review]. Cleve Clin J Med 1997;64:143.
21. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US Population Data [Review]. Arch Intern Med 1993;153:598.
22. Alderman MH. Non-pharmacological treatment of hypertension. Lancet 1994;344;307.
23. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in over-weight hypertensive patients. N Engl J Med 1978; 298:1.
24. Friedman GD, Klatsky AL, Siegelaub AB. Alcohol, tobacco, and hypertension. Hypertension 1982;4(5 Pt2):III143.
25. Maheswaran R, Beevers M, Beevers DG. Effectiveness of advice to reduce alcohol consumption in hypertensive patients. Hypertension 1992;19:79.
26. Witteman JC, Willett WC, Stampfer MJ, et al. A prospective study of nutritional factors and hypertension among US women. Circulation 1989;80:1320.
27. Dahl LK. Possible role of salt intake in the development of essential hypertension. In: Cottier Ṗ, Bock DK, eds. Essential hypertension - An international symposium. Berlin: Springer-Verlag, 1960:53.
28. Longworth DL, Drayer JI, Weber MA, Laragh JH. Divergent blood pressure responses during short-term sodium restriction in hypertension. Clin Pharmacol Ther 1980;27:544.
29. Alderman MH, Madhavan S, Cohen H, Sealey JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension 1995;25:1144.
30. Hanley PC, Zinsmeister AR, Clements IP, Bove AA, Brown ML, Gibbons RJ. Gender-related differences in cardiac response to supine exercise assessed by radionuchde angiography. J Am Coll Cardiol 1989;13: 624.
31. Willich SN, Lewis M, Lowel H, Arntz H-R, Schubert F, Schroder R. Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group. N Engl J Med 1993;329:1684.
32. Fagard R, M'Buyamba-Kabangu JR, Staesen J, Vanhees L, Amery A. Physical activity and blood pressure. In: Bulpitt CJ, ed. Handbook of hypertension. Vol. 6: Epidemiology of hypertension. Amsterdam: Elsevier, 1985:104.
33. Eisenberg DM, Delbanco TL, Berkey CS, et al. Cognitive behavioral techniques for hypertension: Are they effective? [Review] Ann Intern Med 1993;118:964.
34. Lewis CE, Grandits A, Flack J, McDonald R, Elmer PJ. Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study. Arch Intern Med 1996;156:377.
35. The Fifth Report of the Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure (JNC-V). Arch Intern Med 1993;153:154.
36. Weber MA, Laragh JH. The JNC-V report: What does it contribute? Cardiovasc Rev Rep, July 1993, p. 8.
37. Psaty BM, Smith NL, Siscovick DS, et al. Health out-comes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997;277:739.
38. Jerome M, Xakellis GC, Angstman G, Patchin W. Initial medication selection for treatment of hypertension in an open-panel HMO. J Am Board Fam Pract 1995;8:1.
39. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosderotic Therapy (INTACT). Intact Group Investigators. Lancet 1990;335:1109.
40. The HINT Research Group. Early treatment of unstable angina in the coronary care unit: A randomised, double-blind, placebo-controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of the Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. Br Heart J 1986; 56:400.
41. Goldbourt R, Behar S, Reicher-Reiss H, Zion M, Madelzweig L, Kaplinsky E, for the SPRINT Study Group. Early administration of nifedipine in suspected acute myocardial infarction: The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. Arch Intern Med 1993;153:345.
42. Thadani U, Sellner SR, Glasser S, et al. Double-blind, dose-response placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. Circulation 1991;84:2398.
43. Scheidt S, LeWinter MM, Hermanovich J, Venkataraman K, Freedman D. Efficacy and safety of nicardipine for chronic, stable angina pectoris: A multicenter randomized trial. Am J Cardiol 1986;58:715.
44. Frishman WH, Bryzinski BS, Coulson LR, et al. A multifactorial trial design to assess combination therapy in hypertension: Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994;154:1461.
45. Weir MR. A new antihypertensive strategy to minimize dose-related side effects: Low dose multimechanism therapy. Adv Ther 1993;6:293.
46. Neutel JM, Rolf CN, Valentine SN, Li J, Lucas C, Marmorstein BL. Low-dose combination therapy as first line treatment of mild to moderate hypertension: The efficacy and safety of bisoprolol HCTZ versus amlodipine, enalapril and placebo. Cardiovasc Rev Rep 1996;17:1.
47. Prisant LM, Weir MR, Papademetriou V, et al. Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment. Am Heart J 1995;130:359.
48. Papademetriou V, Prisant LM, Neutel MJ, et al. Influence of race and gender on the efficacy and safety of bisoprolol/6.25 mg HCTZ (Z), amlodipine (A), and enalapril (E) in males/females and blacks/non-blacks. Presented at American Society of Hypertension Conference, San Francisco, CA, May 30, 1997.
49. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke and coronary heart disease: Part 2. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827.
50. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in order persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255.
51. Dahlof B, Lindholn LH, Hansson L, Scherston B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-hypertension). Lancet 1991;338:1281.
52. Insua JT, Sacks HS, Lau TS, et al. Drug treatment of hypertension in the elderly: A meta-analysis. Ann Intern Med 1994;121:355.
53. Kaplan NM. The treatment of hypertension in women [Review]. Arch Intern Med 1995;155:563.
54. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: Principal results. Br Med J 1985;291:97.
55. Rosenthal E. High blood pressure may pose less of a danger for women. The New York Times, September 4, 1991.
56. Malatino LS, Glen L, Wilson ESB. The effects of low dose estrogen-progesterone oral contraceptives on blood pressure and the renin-angiotensin system. Curr Ther Res 1988;43:743.
57. Crane MG, Harris JJ. Estrogen and hypertension: Effect of discontinuing estrogens on blood pressure, exchangeable sodium, and the renin-aldosterone system. Am J Med Sci 1978;276:33.
58. Godsland IF, Walton C, Felton C, Proudier A, Patel A, Wynn V. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab 1992;74:64.
59. Hannaford PC, Croft PR, Kay CR. Oral contraception and stroke. Evidence from the Royal College of General Practitioners' Oral Contraception Study. Stroke 1994;25:935.
60. Barrett-Connor E, Wingard DL, Criqui MH. Postmenopausal estrogen use and heart disease risk factors in the 1980s. Rancho Bernardo. Calif., revisited. JAMA 1989;261:2095.
61. Carleton H, Forsythe A, Flores R. Remote prognosis of preeclampsia in women 25 years old and younger. Am J Obstet Gynecol 1988;159:156.
62. Sibai BM. Treatment of hypertension in pregnant women [Review]. N Engl J Med 1996;335:257.
63. Sibai BM, Grossman RA, Grossman HG. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol 1984;150: 831.